SCHEMBL409640

SCHEMBL409640

C=C(C)C(=O)OC(C)N1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.37
ALDH1A1 P00352 3/20 0.35
FDPS P14324 2/20 0.31
CHRNA1 P02708 2/20 0.31
CHRNG P07510 2/20 0.31
CHRNB1 P11230 2/20 0.31
CHRNB2 P17787 2/20 0.31
SLC6A2 P23975 2/20 0.31
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31
CHRNA4 P43681 2/20 0.31
SLC6A3 Q01959 2/20 0.31
CHRND Q07001 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
MAOB P27338 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
DPP7 Q9UHL4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817068 0.98 TSHR (0.38) TSHRALDH1A1
SCHEMBL28167884 0.93 TDP1 (0.39) TSHRALDH1A1DPP7
Piperazine SCHEMBL28139239 0.92 CA2 (0.33) TSHRALDH1A1
Nitric Acid SCHEMBL1403309 0.91 SLC6A2 (0.34) TSHRALDH1A1SLC6A2CHRNB4CHRNA3
SCHEMBL3883739 0.90 TSHR (0.41) TSHRALDH1A1KMT2A
SCHEMBL5529837 0.84 CYP1A2 (0.36) TSHRALDH1A1MEN1KMT2A
SCHEMBL6570452 0.82 TSHR (0.41) TSHRALDH1A1KMT2A
SCHEMBL93248 0.82 ALDH1A1 (0.38) TSHRALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL9807347 0.82 TSHR (0.35) TSHRALDH1A1
Ethane SCHEMBL28247372 0.81 ALDH1A1 (0.37) TSHRALDH1A1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115785328-A Partially crosslinked PMMA and preparation method of composite material thereof 郑州中科新兴产业技术研究院 2023-03-14 CN claimed
CN-115010899-A Preparation method of polyurea acrylate oligomer, polyurea acrylate oligomer and application method of polyurea acrylate oligomer 浙江大学 2022-09-06 CN claimed
CN-1878800-A pH sensitive polymer and process for preparation thereof COUNCIL SCIENT IND RES (IN) 2006-12-13 CN claimed
EP-0484384-B1 PIEZOELECTRIC CELL GROWTH BIOSENSING METHOD AND SYSTEM E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-09-22 EP claimed
US-5135852-A Measuring resonant frequency changes caused by deposition of polymeric complex on electrode; incubating microorganisms, acidification, precipitation E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-04 US claimed
EP-0484384-A1 PIEZOELECTRIC CELL GROWTH BIOSENSING METHOD AND SYSTEM. DU PONT (US) 1992-05-13 EP claimed
EP-0199306-B1 WASH-OFF FILM CONTAINING SYNTHETIC AMPHOTERIC POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-03-11 EP claimed
WO-1991001381-A1 PIEZOELECTRIC CELL GROWTH BIOSENSING METHOD AND SYSTEM E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-02-07 WO claimed
US-4818790-A Room-temperature-curable resin composition DAINIPPON INK AND CHEMICALS, INC. (JP) 1989-04-04 US claimed
US-4761436-A Contact lens comprising triorganovinylsilane polymers SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-08-02 US claimed
US-4735887-A ACRYLIC MONOMERS COMPRISING A CARBOXYLIC ACID, PRIM-AMINOALKYL ACRYLATE AND SEC OR TERT-AMINOALKYL ACRYLATE; GELATIN REPLACEMENT IN PHOTOGRAPHIC LAYERS; RESOLUTION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-04-05 US claimed
EP-0119713-B1 LIQUID ELECTROGRAPHIC DEVELOPERS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-10-07 EP claimed
EP-0220919-A2 Contact lens Shin-Etsu Chemical Co., Ltd. (JP) 1987-05-06 EP claimed
EP-0199306-A2 Wash-off film containing synthetic amphoteric polymers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-10-29 EP claimed
US-20260125526-A1 Free Standing Metal-Ion Doped Thin Films Silverpeutics, Inc. (US) 2026-05-07 US disclosed
EP-3574909-B1 POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING IMBED BIOSCIENCES INC (US) 2026-03-04 EP disclosed
US-20260000805-A1 METHODS AND COMPOSITIONS FOR WOUND HEALING IMBED BIOSCIENCES INC (US) 2026-01-01 US disclosed
US-3990381-A Hydrophilic polymer coating for underwater structures NATIONAL PATENT DEVELOPMENT CORPORATION (US) 1976-11-09 US disclosed
US-3966902-A HYDROXYALKYL UNSATURATED CARBOXYLATE, BOUND AL, ZN, OR ZR AIRWICK INDUSTRIES, INC. (US) 1976-06-29 US disclosed
US-3966847-A Contact lens from hydrophilic gel polymers of polyvinylpyrrolidone and hydroxyalkyl methacrylate SEIDERMAN MAURICE 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260000805-A1 METHODS AND COMPOSITIONS FOR WOUND HEALING PCNA, ARG1, PLOD3 TSHR 3691/4885ALDH1A1 3814/4885FDPS 4314/4885
US-20260125526-A1 Free Standing Metal-Ion Doped Thin Films CUTA, FIBP, PDGFA TSHR 4279/4885ALDH1A1 4153/4885FDPS 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.